Blog - QualityStocks

TuesdayMay 12, 2026 12:02 pm

QualityStocksNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Commences 2026 Drilling at Murdock Mountain Project

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) has commenced drilling on the first hole of its 2026 exploration program at the Murdock Mountain Project, with initial deep drill hole MM26-7 designed as a 100-meter step-back from last fall’s MM25-1 to further evaluate the thickness, continuity and phosphate grade characteristics of the Meade Peak Upper Phosphatic Zone at depth. The company said minor technical drilling issues were identified and are being addressed by contractor FTE Drilling, with operations expected to resume shortly and no material delays anticipated. To view the full press release, visit https://ibn.fm/oieTp Nevada Organic…

TuesdayMay 12, 2026 11:51 am

QualityStocksNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation

This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF) announced its placement in a BioMedWire editorial examining the evolution of GLP-1 therapies and emerging innovation in obesity and metabolic disease treatment. The editorial highlights SureNano’s subsidiary GlucaPharm Inc. and its GEP-44 program, a novel triple agonist peptide designed to improve efficacy, tolerability and delivery flexibility in the rapidly expanding GLP-1 market, as demand continues to grow for next-generation therapies targeting obesity, type 2 diabetes and related chronic conditions. To view the full press release, visit https://ibn.fm/pzQjm About SureNano Science Ltd. SureNano Science Ltd. (CSE: SURE) is a Canadian life sciences company focused on acquiring, developing, and advancing innovative pharmaceutical…

TuesdayMay 12, 2026 11:08 am

QualityStocksNewsBreaks – Qdrant Powers Sapu AI Platform Indexing 28 Million PubMed Abstracts to Accelerate Cancer Research

Qdrant’s vector database infrastructure supports the AI-powered research platform used by SAPU Bioscience, a subsidiary of Oncotelic Therapeutics Inc. (OTCQB: OTLC), enabling large-scale biomedical literature analysis SAPU’s platform has indexed 28 million PubMed abstracts into a single searchable collection, supporting AI-assisted research workflows and peer-reviewed scientific output The AI ecosystem aligns with Oncotelic’s broader strategy of integrating artificial intelligence, nanoparticle development and accelerated drug discovery platforms In a blog post by Daniel Azoulai, Qdrant highlighted how Sapu, an early-stage biopharmaceutical company developing treatments for hard-to-treat cancers, uses Qdrant Cloud infrastructure to power an AI research platform capable of indexing and querying all 28 million PubMed abstracts in a single searchable collection, helping accelerate biomedical…

TuesdayMay 12, 2026 10:45 am

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Reports Broad Gold Intercepts at Swanson Project

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. Figure 1: Plan View of Swanson Deposit with currently reported drill holes LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) reported results from its ongoing drilling program at the Swanson Gold Project, highlighting broad and continuous gold mineralization that supports expansion potential beyond the current mineral resource model and planned open-pit limits. Key intercepts included 2.95 g/t gold over 80.0 meters, 2.37 g/t gold over 88.05 meters and 1.29 g/t gold over 93.85 meters, with drilling targeting previously under-tested areas between 90 and 250 meters…

TuesdayMay 12, 2026 10:35 am

QualityStocksNewsBreaks – Bullish (NYSE: BLSH) to Acquire Equiniti in $4.2 Billion Transaction

Bullish (NYSE: BLSH) has entered into a definitive agreement to acquire Equiniti, the parent company of Notified and a global transfer agent and shareholder services provider, in a transaction valued at $4.2 billion. The acquisition is designed to position Bullish at the forefront of blockchain-native capital markets infrastructure by combining its institutional digital asset platform with Equiniti’s regulated transfer agent capabilities, which support nearly 3,000 public companies and more than 20 million verified shareholders. Bullish said the combination is intended to create a global transfer agent platform for tokenized securities, addressing what it views as a key infrastructure gap as…

TuesdayMay 12, 2026 10:00 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) CEO Featured on TechMediaWire Podcast Discussing AI Voice Detection Platform

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Founder and CEO Justin Hanka joined the latest episode of the TechMediaWire Podcast to discuss the company’s artificial intelligence-driven voice analysis technology designed to detect drug and alcohol intoxication through noninvasive speech analysis. During the interview, Hanka outlined the limitations of traditional testing methods and described MindBio’s commercial focus on regulated workplace environments such as mining, where the company believes its scalable detection platform could improve safety by expanding real-time intoxication screening capabilities. To view the…

TuesdayMay 12, 2026 9:45 am

QualityStocksNewsBreaks – Lunai Bioworks, Inc. (NASDAQ: LNAI) Targets Alleged Naked Short Sellers in Securities Fraud Lawsuit

Lunai Bioworks (NASDAQ: LNAI) is the plaintiff in a federal securities fraud lawsuit filed in Delaware by national law firms Dickinson Wright and Fox Rothschild, alleging that unidentified “naked” short sellers engaged in a coordinated scheme to manipulate trading in the company’s common stock. The complaint alleges repeated violations of SEC Regulation SHO, including failures to deliver shares reaching as high as 234.6 times the maximum baseline daily rate and periods in which failures to deliver allegedly represented 81.6% of the company’s total outstanding shares. According to the complaint, certain trading activity allegedly exceeded Lunai’s available share count, including more than…

TuesdayMay 12, 2026 9:20 am

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Featured in BioMedWire Editorial on AI-Powered Intoxication Detection

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced its placement in a BioMedWire editorial exploring emerging technologies aimed at improving intoxication detection across law enforcement, workplace safety and healthcare settings. The editorial highlights MindBio’s development of an artificial intelligence-driven voice analysis platform designed to detect real-time impairment from short speech samples, positioning the company within a growing movement toward noninvasive diagnostic technologies with potential applications across public safety, regulatory enforcement and health monitoring. To view the full press release, visit https://ibn.fm/Ib2KB About MindBio…

TuesdayMay 12, 2026 9:10 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on CNS Drug Delivery Innovation

Oncotelic Therapeutics (OTCQB: OTLC) announced its placement in a BioMedWire editorial examining emerging breakthroughs in central nervous system drug delivery and the growing market opportunities tied to overcoming the blood-brain barrier. The editorial highlights Oncotelic’s proprietary intranasal nose-to-brain delivery platform, which is designed to enable rapid, targeted therapeutic access to the brain, positioning the company within a broader industry effort to advance next-generation treatments for neurological disease, biodefense applications and other CNS-related conditions. To view the full press release, visit https://ibn.fm/Y8E3U About Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of oncology and immunotherapy…

TuesdayMay 12, 2026 9:00 am

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Featured in AINewsWire Editorial on Autonomous Drone Warfare Software

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced its placement in an AINewsWire editorial exploring the growing role of software-driven autonomy in modern drone warfare. The editorial examines how low-cost drones are reshaping military strategy while highlighting the increasing importance of software that enables autonomous navigation and precision targeting in GPS-denied and electronically contested environments, positioning SPARC AI’s software-only platform as a potential solution for next-generation drone operations. To view the full press release, visit https://ibn.fm/owX2v About SPARC AI Inc. SPARC AI is…

Site Search

Company Search